Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Explore various ways to monetize your skills and effectively manage your debt. Learn how to turn your expertise into extra income.
19,574 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
A standout earnings beat pushed Clear Secure stock higher on Wednesday as revenue, user growth, and guidance surprise...
Google’s Gmail guru unveils a three-adopter framework for AI use, signaling a trust-first approach as Gmail rolls out...
Gas costs ripple through every link of retail, from trucking to checkout. This article breaks down how could sudden j...
A wave of enthusiasm for AI infrastructure helped Tower Semiconductor leap higher this week. Investors spotlighted si...
Investors are weighing a shift from high-growth tech to more income-driven energy plays as AI-era capex creates uncer...
A surge of tech employees are tapping a little-known 401(k) feature to add thousands to their Roth retirement account...
Satellogic’s 2026 earnings hinge on a mix of recurring data licenses, expanding contracts, and efficient scaling. Thi...
A claim of six primary wins is fueling talk of a pro-crypto mandate. This article breaks down what that signal could ...
A trio of monthly-paying funds could steady-cash a $100,000 portfolio to about $750 a month, aiming for $9,000 in ann...
Retail investors are watching Walmart+ closely as a potential catalyst for stronger customer loyalty and bigger baske...
A surge in Palo Alto Networks stock in May grabbed headlines, but a reverse move in June left investors weighing the ...